HK1000113A1 - Vaccine composition - Google Patents

Vaccine composition

Info

Publication number: HK1000113A1
Authority: HK; Hong Kong
Prior art keywords: vaccine composition; vaccine; composition
Prior art date: 1989-01-23

Application number

HK97101612A

Other languages

English (en)

Inventor

Alan James Husband

Original Assignee

Auspharm Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-01-23

Filing date

1997-07-29

Publication date

1997-12-05

1997-07-29 Application filed by Auspharm Int Ltd filed Critical Auspharm Int Ltd

1997-12-05 Publication of HK1000113A1 publication Critical patent/HK1000113A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

HK97101612A 1989-01-23 1997-07-29 Vaccine composition HK1000113A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AUPJ236889		1989-01-23
PCT/AU1990/000014 WO1990007935A1 (en)	1989-01-23	1990-01-19	Vaccine composition

Publications (1)

Publication Number	Publication Date
HK1000113A1 true HK1000113A1 (en)	1997-12-05

Family

ID=3773656

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK97101612A HK1000113A1 (en)	1989-01-23	1997-07-29	Vaccine composition

Country Status (8)

Country	Link
EP (1)	EP0454735B1 (xx)
AU (1)	AU638970B2 (xx)
DE (1)	DE69027112T2 (xx)
DK (1)	DK0454735T3 (xx)
HK (1)	HK1000113A1 (xx)
NZ (1)	NZ232190A (xx)
WO (1)	WO1990007935A1 (xx)
ZA (1)	ZA90474B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2104731T3 (es) *	1990-11-08	1997-10-16	Univ London	Micobacterium utilizado como adyuvante para antigenos.
CA2083553A1 (en) *	1991-11-25	1993-05-26	Kuniharu Seki	Immunogen composition
AUPN178995A0 (en) *	1995-03-16	1995-04-13	University Of Melbourne, The	Antigen composition
UA56132C2 (uk) *	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6406704B1 (en)	1996-08-29	2002-06-18	Genesis Research And Development Corporation Limited	Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en)	1996-08-29	2001-09-04	Genesis Research & Development Corporation Limited	Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) *	1996-08-29	2000-12-12	Genesis Researth And Development Corporation Limited	Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) *	1996-08-29	1999-11-16	Genesis Research And Development Corporation Limited	Compounds and methods for treatment and diagnosis of mycobacterial infections
CA2302554C (en) *	1997-09-05	2007-04-10	Smithkline Beecham Biologicals S.A.	Oil in water emulsions containing saponins
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US5968524A (en) *	1997-12-23	1999-10-19	Genesis Research & Development Corp.	Methods and compounds for the treatment of immunologically-mediated psoriasis
US6328978B1 (en)	1997-12-23	2001-12-11	Genesis Research & Development Corp. Ltd.	Methods for the treatment of immunologically-mediated skin disorders
US6350457B1 (en)	1999-06-02	2002-02-26	Genesis Research & Development Corporation Limited	Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
MX365868B (es)	2005-12-29	2019-06-18	Boehringer Ingelheim Vetmedica Inc	Composiciones inmunogenicas de pcv2 multivalentes y metodos de producir composiciones de este tipo.
PT2371383E (pt)	2005-12-29	2015-11-24	Boehringer Ingelheim Vetmed	Utilização de uma composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
EP2859900A1 (en)	2006-12-11	2015-04-15	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
HUE044410T2 (hu)	2006-12-15	2019-10-28	Boehringer Ingelheim Animal Health Usa Inc	Egydózisú anti-PCV2 sertés vakcina
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
BRPI0907438A2 (pt)	2008-01-23	2015-08-04	Boehringer Ingelheim Vetmed	Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
CA2925281C (en)	2013-09-25	2022-05-03	Zoetis Services Llc	Pcv2b divergent vaccine composition and methods of use
ES2778425T3 (es)	2013-10-02	2020-08-10	Boehringer Ingelheim Animal Health Usa Inc	Variante de la proteína ORF2 del PCV2 y partículas similares a virus compuestas por esta

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5540568B2 (xx) *	1972-10-05	1980-10-18
ZA738364B (en) *	1972-12-04	1974-09-25	Rit Rech Ind Therapeut	Piglet colibacillosis vaccines and process for their preparation
FR2298337A1 (fr) *	1975-01-23	1976-08-20	Pasteur Institut	Procede de conservation de vaccins contenant des mycobacteries vivantes
US4167560A (en) *	1977-04-12	1979-09-11	Texas Vet Lab, Inc.	Polyvalent shipping fever vaccine
CA1188986A (en) *	1981-04-30	1985-06-18	Real Lallier	Isolation of escherichia coli heat-stable enterotoxin of porcine origin
CA1338705C (en) *	1981-10-22	1996-11-12	Roy Curtiss Iii	Vaccines obtained from antigenic gene products of recombinant genes
FR2565825B1 (fr) *	1984-06-15	1990-07-13	Centre Nat Rech Scient	Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
US4806350A (en) *	1986-04-18	1989-02-21	Norden Laboratories, Inc.	Vaccine formulation
EP0283840A3 (en) *	1987-03-26	1989-08-09	Ml Technology Ventures, L.P.	Mycoplasma hyopneumoniae antigen and uses therefor

1990
- 1990-01-19 WO PCT/AU1990/000014 patent/WO1990007935A1/en active IP Right Grant
- 1990-01-19 AU AU49599/90A patent/AU638970B2/en not_active Ceased
- 1990-01-19 EP EP90902112A patent/EP0454735B1/en not_active Expired - Lifetime
- 1990-01-19 DK DK90902112.3T patent/DK0454735T3/da active
- 1990-01-19 DE DE69027112T patent/DE69027112T2/de not_active Expired - Fee Related
- 1990-01-23 NZ NZ232190A patent/NZ232190A/xx unknown
- 1990-01-23 ZA ZA90474A patent/ZA90474B/xx unknown
1997
- 1997-07-29 HK HK97101612A patent/HK1000113A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0454735T3 (da)	1996-10-07
AU4959990A (en)	1990-08-13
AU638970B2 (en)	1993-07-15
DE69027112T2 (de)	1997-01-09
WO1990007935A1 (en)	1990-07-26
NZ232190A (en)	1991-10-25
DE69027112D1 (de)	1996-06-27
EP0454735B1 (en)	1996-05-22
EP0454735A4 (en)	1992-01-15
ZA90474B (en)	1990-10-31
EP0454735A1 (en)	1991-11-06

Publication	Publication Date	Title
GB8924438D0 (en)	1989-12-20	Vaccine composition
ZA90474B (en)	1990-10-31	Vaccine composition
GB8921470D0 (en)	1989-11-08	Vaccines
GB8908361D0 (en)	1989-06-01	Composition
GR3019065T3 (en)	1996-05-31	Vaccine Composition
GB8918689D0 (en)	1989-09-27	25/15 vaccine
EP0386359A3 (en)	1990-11-28	Konjak-containing composition
GB2231575B (en)	1992-07-08	Command-curable composition
GB8916151D0 (en)	1989-08-31	Composition
GB9012302D0 (en)	1990-07-18	Composition
GB8912496D0 (en)	1989-07-19	Vaccines
ZA90766B (en)	1990-11-28	Vaccine composition
EP0453452A4 (en)	1991-11-21	Vaccine
EP0434164A3 (en)	1993-01-13	Frying-fat composition
HU204716B (en)	1992-02-28	Raney-catalyzer composition
AU640364C (en)	1995-03-30	Vaccine composition
ZA909516B (en)	1991-08-28	Novel vaccine
GB8922651D0 (en)	1989-11-22	Vaccine
IE900354L (en)	1990-08-01	Vaccine composition
GB8926832D0 (en)	1990-01-17	Vaccines
GB8919940D0 (en)	1989-10-18	Vaccines
GB8914532D0 (en)	1989-08-09	Vaccines
IE892784L (en)	1990-02-28	Vaccines
GB8917942D0 (en)	1989-09-20	Vaccines
GB8917601D0 (en)	1989-09-13	Composition

Legal Events

Date	Code	Title	Description
2004-12-15	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)